Targeted DNA & RNA Sequencing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

• Description
• Table of Contents
• Table of Figures
• PDF Download

• Description
• Table of Contents
• Table of Figures
• PDF Download

Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest. It offers both quantitative and qualitative information.

The global market for Targeted DNA & RNA Sequencing was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

North American market for Targeted DNA & RNA Sequencing was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Targeted DNA & RNA Sequencing was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Targeted DNA & RNA Sequencing was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of Targeted DNA & RNA Sequencing include Illumina, Inc., F. Hoffmann-La Roche Ltd, Agilent Technologies, GATC Biotech Ag, Oxford Nanopore Technologies, Thermo Fisher Scientific, Inc., DNASTAR Inc., QIAGEN and BGI, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Targeted DNA & RNA Sequencing, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Targeted DNA & RNA Sequencing by region & country, by Type, and by Application.

The Targeted DNA & RNA Sequencing market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Targeted DNA & RNA Sequencing.

Market Segmentation

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Targeted DNA & RNA Sequencing manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Targeted DNA & RNA Sequencing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Targeted DNA & RNA Sequencing in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

 1 Market Overview
    1.1 Targeted DNA & RNA Sequencing Product Introduction
    1.2 Global Targeted DNA & RNA Sequencing Market Size Forecast
    1.3 Targeted DNA & RNA Sequencing Market Trends & Drivers
        1.3.1 Targeted DNA & RNA Sequencing Industry Trends
        1.3.2 Targeted DNA & RNA Sequencing Market Drivers & Opportunity
        1.3.3 Targeted DNA & RNA Sequencing Market Challenges
        1.3.4 Targeted DNA & RNA Sequencing Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Targeted DNA & RNA Sequencing Players Revenue Ranking (2023)
    2.2 Global Targeted DNA & RNA Sequencing Revenue by Company (2019-2024)
    2.3 Key Companies Targeted DNA & RNA Sequencing Manufacturing Base Distribution and Headquarters
    2.4 Key Companies Targeted DNA & RNA Sequencing Product Offered
    2.5 Key Companies Time to Begin Mass Production of Targeted DNA & RNA Sequencing
    2.6 Targeted DNA & RNA Sequencing Market Competitive Analysis
        2.6.1 Targeted DNA & RNA Sequencing Market Concentration Rate (2019-2024)
        2.6.2 Global 5 and 10 Largest Companies by Targeted DNA & RNA Sequencing Revenue in 2023
        2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted DNA & RNA Sequencing as of 2023)
    2.7 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 DNA-based Targeted Sequencing
        3.1.2 RNA-based Targeted Sequencing
    3.2 Global Targeted DNA & RNA Sequencing Sales Value by Type
        3.2.1 Global Targeted DNA & RNA Sequencing Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Targeted DNA & RNA Sequencing Sales Value, by Type (2019-2030)
        3.2.3 Global Targeted DNA & RNA Sequencing Sales Value, by Type (%) (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Human Biomedical Research
        4.1.2 Plant & Animal Sciences
        4.1.3 Drug Discovery
        4.1.4 Others
    4.2 Global Targeted DNA & RNA Sequencing Sales Value by Application
        4.2.1 Global Targeted DNA & RNA Sequencing Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Targeted DNA & RNA Sequencing Sales Value, by Application (2019-2030)
        4.2.3 Global Targeted DNA & RNA Sequencing Sales Value, by Application (%) (2019-2030)

 5 Segmentation by Region
    5.1 Global Targeted DNA & RNA Sequencing Sales Value by Region
        5.1.1 Global Targeted DNA & RNA Sequencing Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Targeted DNA & RNA Sequencing Sales Value by Region (2019-2024)
        5.1.3 Global Targeted DNA & RNA Sequencing Sales Value by Region (2025-2030)
        5.1.4 Global Targeted DNA & RNA Sequencing Sales Value by Region (%), (2019-2030)
    5.2 North America
        5.2.1 North America Targeted DNA & RNA Sequencing Sales Value, 2019-2030
        5.2.2 North America Targeted DNA & RNA Sequencing Sales Value by Country (%), 2023 VS 2030
    5.3 Europe
        5.3.1 Europe Targeted DNA & RNA Sequencing Sales Value, 2019-2030
        5.3.2 Europe Targeted DNA & RNA Sequencing Sales Value by Country (%), 2023 VS 2030
    5.4 Asia Pacific
        5.4.1 Asia Pacific Targeted DNA & RNA Sequencing Sales Value, 2019-2030
        5.4.2 Asia Pacific Targeted DNA & RNA Sequencing Sales Value by Country (%), 2023 VS 2030
    5.5 South America
        5.5.1 South America Targeted DNA & RNA Sequencing Sales Value, 2019-2030
        5.5.2 South America Targeted DNA & RNA Sequencing Sales Value by Country (%), 2023 VS 2030
    5.6 Middle East & Africa
        5.6.1 Middle East & Africa Targeted DNA & RNA Sequencing Sales Value, 2019-2030
        5.6.2 Middle East & Africa Targeted DNA & RNA Sequencing Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Targeted DNA & RNA Sequencing Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Targeted DNA & RNA Sequencing Sales Value
    6.3 United States
        6.3.1 United States Targeted DNA & RNA Sequencing Sales Value, 2019-2030
        6.3.2 United States Targeted DNA & RNA Sequencing Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Targeted DNA & RNA Sequencing Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Targeted DNA & RNA Sequencing Sales Value, 2019-2030
        6.4.2 Europe Targeted DNA & RNA Sequencing Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Targeted DNA & RNA Sequencing Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Targeted DNA & RNA Sequencing Sales Value, 2019-2030
        6.5.2 China Targeted DNA & RNA Sequencing Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Targeted DNA & RNA Sequencing Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Targeted DNA & RNA Sequencing Sales Value, 2019-2030
        6.6.2 Japan Targeted DNA & RNA Sequencing Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Targeted DNA & RNA Sequencing Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Targeted DNA & RNA Sequencing Sales Value, 2019-2030
        6.7.2 South Korea Targeted DNA & RNA Sequencing Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Targeted DNA & RNA Sequencing Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Targeted DNA & RNA Sequencing Sales Value, 2019-2030
        6.8.2 Southeast Asia Targeted DNA & RNA Sequencing Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Targeted DNA & RNA Sequencing Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Targeted DNA & RNA Sequencing Sales Value, 2019-2030
        6.9.2 India Targeted DNA & RNA Sequencing Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Targeted DNA & RNA Sequencing Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 Illumina, Inc.
        7.1.1 Illumina, Inc. Profile
        7.1.2 Illumina, Inc. Main Business
        7.1.3 Illumina, Inc. Targeted DNA & RNA Sequencing Products, Services and Solutions
        7.1.4 Illumina, Inc. Targeted DNA & RNA Sequencing Revenue (US$ Million) & (2019-2024)
        7.1.5 Illumina, Inc. Recent Developments
    7.2 F. Hoffmann-La Roche Ltd
        7.2.1 F. Hoffmann-La Roche Ltd Profile
        7.2.2 F. Hoffmann-La Roche Ltd Main Business
        7.2.3 F. Hoffmann-La Roche Ltd Targeted DNA & RNA Sequencing Products, Services and Solutions
        7.2.4 F. Hoffmann-La Roche Ltd Targeted DNA & RNA Sequencing Revenue (US$ Million) & (2019-2024)
        7.2.5 F. Hoffmann-La Roche Ltd Recent Developments
    7.3 Agilent Technologies
        7.3.1 Agilent Technologies Profile
        7.3.2 Agilent Technologies Main Business
        7.3.3 Agilent Technologies Targeted DNA & RNA Sequencing Products, Services and Solutions
        7.3.4 Agilent Technologies Targeted DNA & RNA Sequencing Revenue (US$ Million) & (2019-2024)
        7.3.5 GATC Biotech Ag Recent Developments
    7.4 GATC Biotech Ag
        7.4.1 GATC Biotech Ag Profile
        7.4.2 GATC Biotech Ag Main Business
        7.4.3 GATC Biotech Ag Targeted DNA & RNA Sequencing Products, Services and Solutions
        7.4.4 GATC Biotech Ag Targeted DNA & RNA Sequencing Revenue (US$ Million) & (2019-2024)
        7.4.5 GATC Biotech Ag Recent Developments
    7.5 Oxford Nanopore Technologies
        7.5.1 Oxford Nanopore Technologies Profile
        7.5.2 Oxford Nanopore Technologies Main Business
        7.5.3 Oxford Nanopore Technologies Targeted DNA & RNA Sequencing Products, Services and Solutions
        7.5.4 Oxford Nanopore Technologies Targeted DNA & RNA Sequencing Revenue (US$ Million) & (2019-2024)
        7.5.5 Oxford Nanopore Technologies Recent Developments
    7.6 Thermo Fisher Scientific, Inc.
        7.6.1 Thermo Fisher Scientific, Inc. Profile
        7.6.2 Thermo Fisher Scientific, Inc. Main Business
        7.6.3 Thermo Fisher Scientific, Inc. Targeted DNA & RNA Sequencing Products, Services and Solutions
        7.6.4 Thermo Fisher Scientific, Inc. Targeted DNA & RNA Sequencing Revenue (US$ Million) & (2019-2024)
        7.6.5 Thermo Fisher Scientific, Inc. Recent Developments
    7.7 DNASTAR Inc.
        7.7.1 DNASTAR Inc. Profile
        7.7.2 DNASTAR Inc. Main Business
        7.7.3 DNASTAR Inc. Targeted DNA & RNA Sequencing Products, Services and Solutions
        7.7.4 DNASTAR Inc. Targeted DNA & RNA Sequencing Revenue (US$ Million) & (2019-2024)
        7.7.5 DNASTAR Inc. Recent Developments
    7.8 QIAGEN
        7.8.1 QIAGEN Profile
        7.8.2 QIAGEN Main Business
        7.8.3 QIAGEN Targeted DNA & RNA Sequencing Products, Services and Solutions
        7.8.4 QIAGEN Targeted DNA & RNA Sequencing Revenue (US$ Million) & (2019-2024)
        7.8.5 QIAGEN Recent Developments
    7.9 BGI
        7.9.1 BGI Profile
        7.9.2 BGI Main Business
        7.9.3 BGI Targeted DNA & RNA Sequencing Products, Services and Solutions
        7.9.4 BGI Targeted DNA & RNA Sequencing Revenue (US$ Million) & (2019-2024)
        7.9.5 BGI Recent Developments
    7.10 Perkin Elmer, Inc.
        7.10.1 Perkin Elmer, Inc. Profile
        7.10.2 Perkin Elmer, Inc. Main Business
        7.10.3 Perkin Elmer, Inc. Targeted DNA & RNA Sequencing Products, Services and Solutions
        7.10.4 Perkin Elmer, Inc. Targeted DNA & RNA Sequencing Revenue (US$ Million) & (2019-2024)
        7.10.5 Perkin Elmer, Inc. Recent Developments
    7.11 Pacific Biosciences of California, Inc.
        7.11.1 Pacific Biosciences of California, Inc. Profile
        7.11.2 Pacific Biosciences of California, Inc. Main Business
        7.11.3 Pacific Biosciences of California, Inc. Targeted DNA & RNA Sequencing Products, Services and Solutions
        7.11.4 Pacific Biosciences of California, Inc. Targeted DNA & RNA Sequencing Revenue (US$ Million) & (2019-2024)
        7.11.5 Pacific Biosciences of California, Inc. Recent Developments
    7.12 Bio-Rad Laboratories, Inc.
        7.12.1 Bio-Rad Laboratories, Inc. Profile
        7.12.2 Bio-Rad Laboratories, Inc. Main Business
        7.12.3 Bio-Rad Laboratories, Inc. Targeted DNA & RNA Sequencing Products, Services and Solutions
        7.12.4 Bio-Rad Laboratories, Inc. Targeted DNA & RNA Sequencing Revenue (US$ Million) & (2019-2024)
        7.12.5 Bio-Rad Laboratories, Inc. Recent Developments
    7.13 Integrated DNA Technologies, Inc.
        7.13.1 Integrated DNA Technologies, Inc. Profile
        7.13.2 Integrated DNA Technologies, Inc. Main Business
        7.13.3 Integrated DNA Technologies, Inc. Targeted DNA & RNA Sequencing Products, Services and Solutions
        7.13.4 Integrated DNA Technologies, Inc. Targeted DNA & RNA Sequencing Revenue (US$ Million) & (2019-2024)
        7.13.5 Integrated DNA Technologies, Inc. Recent Developments
    7.14 RainDance Technologies, Inc.
        7.14.1 RainDance Technologies, Inc. Profile
        7.14.2 RainDance Technologies, Inc. Main Business
        7.14.3 RainDance Technologies, Inc. Targeted DNA & RNA Sequencing Products, Services and Solutions
        7.14.4 RainDance Technologies, Inc. Targeted DNA & RNA Sequencing Revenue (US$ Million) & (2019-2024)
        7.14.5 RainDance Technologies, Inc. Recent Developments
    7.15 PierianDx
        7.15.1 PierianDx Profile
        7.15.2 PierianDx Main Business
        7.15.3 PierianDx Targeted DNA & RNA Sequencing Products, Services and Solutions
        7.15.4 PierianDx Targeted DNA & RNA Sequencing Revenue (US$ Million) & (2019-2024)
        7.15.5 PierianDx Recent Developments
    7.16 Genomatix GmbH
        7.16.1 Genomatix GmbH Profile
        7.16.2 Genomatix GmbH Main Business
        7.16.3 Genomatix GmbH Targeted DNA & RNA Sequencing Products, Services and Solutions
        7.16.4 Genomatix GmbH Targeted DNA & RNA Sequencing Revenue (US$ Million) & (2019-2024)
        7.16.5 Genomatix GmbH Recent Developments
    7.17 Macrogen, Inc.
        7.17.1 Macrogen, Inc. Profile
        7.17.2 Macrogen, Inc. Main Business
        7.17.3 Macrogen, Inc. Targeted DNA & RNA Sequencing Products, Services and Solutions
        7.17.4 Macrogen, Inc. Targeted DNA & RNA Sequencing Revenue (US$ Million) & (2019-2024)
        7.17.5 Macrogen, Inc. Recent Developments

 8 Industry Chain Analysis
    8.1 Targeted DNA & RNA Sequencing Industrial Chain
    8.2 Targeted DNA & RNA Sequencing Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Targeted DNA & RNA Sequencing Sales Model
        8.5.2 Sales Channel
        8.5.3 Targeted DNA & RNA Sequencing Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

List of Tables
    Table 1. Targeted DNA & RNA Sequencing Market Trends
    Table 2. Targeted DNA & RNA Sequencing Market Drivers & Opportunity
    Table 3. Targeted DNA & RNA Sequencing Market Challenges
    Table 4. Targeted DNA & RNA Sequencing Market Restraints
    Table 5. Global Targeted DNA & RNA Sequencing Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Targeted DNA & RNA Sequencing Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Targeted DNA & RNA Sequencing Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Targeted DNA & RNA Sequencing Product Type
    Table 9. Key Companies Time to Begin Mass Production of Targeted DNA & RNA Sequencing
    Table 10. Global Targeted DNA & RNA Sequencing Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted DNA & RNA Sequencing as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Targeted DNA & RNA Sequencing Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Targeted DNA & RNA Sequencing Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Targeted DNA & RNA Sequencing Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Targeted DNA & RNA Sequencing Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Targeted DNA & RNA Sequencing Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Targeted DNA & RNA Sequencing Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Targeted DNA & RNA Sequencing Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Targeted DNA & RNA Sequencing Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Targeted DNA & RNA Sequencing Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Targeted DNA & RNA Sequencing Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Targeted DNA & RNA Sequencing Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Targeted DNA & RNA Sequencing Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Targeted DNA & RNA Sequencing Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Targeted DNA & RNA Sequencing Sales Value by Region (2019-2024) & (%)
    Table 27. Global Targeted DNA & RNA Sequencing Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Targeted DNA & RNA Sequencing Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Targeted DNA & RNA Sequencing Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Targeted DNA & RNA Sequencing Sales Value, (2025-2030) & (US$ Million)
    Table 31. Illumina, Inc. Basic Information List
    Table 32. Illumina, Inc. Description and Business Overview
    Table 33. Illumina, Inc. Targeted DNA & RNA Sequencing Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Targeted DNA & RNA Sequencing Business of Illumina, Inc. (2019-2024)
    Table 35. Illumina, Inc. Recent Developments
    Table 36. F. Hoffmann-La Roche Ltd Basic Information List
    Table 37. F. Hoffmann-La Roche Ltd Description and Business Overview
    Table 38. F. Hoffmann-La Roche Ltd Targeted DNA & RNA Sequencing Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Targeted DNA & RNA Sequencing Business of F. Hoffmann-La Roche Ltd (2019-2024)
    Table 40. F. Hoffmann-La Roche Ltd Recent Developments
    Table 41. Agilent Technologies Basic Information List
    Table 42. Agilent Technologies Description and Business Overview
    Table 43. Agilent Technologies Targeted DNA & RNA Sequencing Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Targeted DNA & RNA Sequencing Business of Agilent Technologies (2019-2024)
    Table 45. Agilent Technologies Recent Developments
    Table 46. GATC Biotech Ag Basic Information List
    Table 47. GATC Biotech Ag Description and Business Overview
    Table 48. GATC Biotech Ag Targeted DNA & RNA Sequencing Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Targeted DNA & RNA Sequencing Business of GATC Biotech Ag (2019-2024)
    Table 50. GATC Biotech Ag Recent Developments
    Table 51. Oxford Nanopore Technologies Basic Information List
    Table 52. Oxford Nanopore Technologies Description and Business Overview
    Table 53. Oxford Nanopore Technologies Targeted DNA & RNA Sequencing Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Targeted DNA & RNA Sequencing Business of Oxford Nanopore Technologies (2019-2024)
    Table 55. Oxford Nanopore Technologies Recent Developments
    Table 56. Thermo Fisher Scientific, Inc. Basic Information List
    Table 57. Thermo Fisher Scientific, Inc. Description and Business Overview
    Table 58. Thermo Fisher Scientific, Inc. Targeted DNA & RNA Sequencing Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Targeted DNA & RNA Sequencing Business of Thermo Fisher Scientific, Inc. (2019-2024)
    Table 60. Thermo Fisher Scientific, Inc. Recent Developments
    Table 61. DNASTAR Inc. Basic Information List
    Table 62. DNASTAR Inc. Description and Business Overview
    Table 63. DNASTAR Inc. Targeted DNA & RNA Sequencing Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Targeted DNA & RNA Sequencing Business of DNASTAR Inc. (2019-2024)
    Table 65. DNASTAR Inc. Recent Developments
    Table 66. QIAGEN Basic Information List
    Table 67. QIAGEN Description and Business Overview
    Table 68. QIAGEN Targeted DNA & RNA Sequencing Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Targeted DNA & RNA Sequencing Business of QIAGEN (2019-2024)
    Table 70. QIAGEN Recent Developments
    Table 71. BGI Basic Information List
    Table 72. BGI Description and Business Overview
    Table 73. BGI Targeted DNA & RNA Sequencing Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Targeted DNA & RNA Sequencing Business of BGI (2019-2024)
    Table 75. BGI Recent Developments
    Table 76. Perkin Elmer, Inc. Basic Information List
    Table 77. Perkin Elmer, Inc. Description and Business Overview
    Table 78. Perkin Elmer, Inc. Targeted DNA & RNA Sequencing Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Targeted DNA & RNA Sequencing Business of Perkin Elmer, Inc. (2019-2024)
    Table 80. Perkin Elmer, Inc. Recent Developments
    Table 81. Pacific Biosciences of California, Inc. Basic Information List
    Table 82. Pacific Biosciences of California, Inc. Description and Business Overview
    Table 83. Pacific Biosciences of California, Inc. Targeted DNA & RNA Sequencing Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Targeted DNA & RNA Sequencing Business of Pacific Biosciences of California, Inc. (2019-2024)
    Table 85. Pacific Biosciences of California, Inc. Recent Developments
    Table 86. Bio-Rad Laboratories, Inc. Basic Information List
    Table 87. Bio-Rad Laboratories, Inc. Description and Business Overview
    Table 88. Bio-Rad Laboratories, Inc. Targeted DNA & RNA Sequencing Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Targeted DNA & RNA Sequencing Business of Bio-Rad Laboratories, Inc. (2019-2024)
    Table 90. Bio-Rad Laboratories, Inc. Recent Developments
    Table 91. Integrated DNA Technologies, Inc. Basic Information List
    Table 92. Integrated DNA Technologies, Inc. Description and Business Overview
    Table 93. Integrated DNA Technologies, Inc. Targeted DNA & RNA Sequencing Products, Services and Solutions
    Table 94. Revenue (US$ Million) in Targeted DNA & RNA Sequencing Business of Integrated DNA Technologies, Inc. (2019-2024)
    Table 95. Integrated DNA Technologies, Inc. Recent Developments
    Table 96. RainDance Technologies, Inc. Basic Information List
    Table 97. RainDance Technologies, Inc. Description and Business Overview
    Table 98. RainDance Technologies, Inc. Targeted DNA & RNA Sequencing Products, Services and Solutions
    Table 99. Revenue (US$ Million) in Targeted DNA & RNA Sequencing Business of RainDance Technologies, Inc. (2019-2024)
    Table 100. RainDance Technologies, Inc. Recent Developments
    Table 101. PierianDx Basic Information List
    Table 102. PierianDx Description and Business Overview
    Table 103. PierianDx Targeted DNA & RNA Sequencing Products, Services and Solutions
    Table 104. Revenue (US$ Million) in Targeted DNA & RNA Sequencing Business of PierianDx (2019-2024)
    Table 105. PierianDx Recent Developments
    Table 106. Genomatix GmbH Basic Information List
    Table 107. Genomatix GmbH Description and Business Overview
    Table 108. Genomatix GmbH Targeted DNA & RNA Sequencing Products, Services and Solutions
    Table 109. Revenue (US$ Million) in Targeted DNA & RNA Sequencing Business of Genomatix GmbH (2019-2024)
    Table 110. Genomatix GmbH Recent Developments
    Table 111. Macrogen, Inc. Basic Information List
    Table 112. Macrogen, Inc. Description and Business Overview
    Table 113. Macrogen, Inc. Targeted DNA & RNA Sequencing Products, Services and Solutions
    Table 114. Revenue (US$ Million) in Targeted DNA & RNA Sequencing Business of Macrogen, Inc. (2019-2024)
    Table 115. Macrogen, Inc. Recent Developments
    Table 116. Key Raw Materials Lists
    Table 117. Raw Materials Key Suppliers Lists
    Table 118. Targeted DNA & RNA Sequencing Downstream Customers
    Table 119. Targeted DNA & RNA Sequencing Distributors List
    Table 120. Research Programs/Design for This Report
    Table 121. Key Data Information from Secondary Sources
    Table 122. Key Data Information from Primary Sources
    Table 123. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Targeted DNA & RNA Sequencing Product Picture
    Figure 2. Global Targeted DNA & RNA Sequencing Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Targeted DNA & RNA Sequencing Sales Value (2019-2030) & (US$ Million)
    Figure 4. Targeted DNA & RNA Sequencing Report Years Considered
    Figure 5. Global Targeted DNA & RNA Sequencing Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Targeted DNA & RNA Sequencing Revenue in 2023
    Figure 7. Targeted DNA & RNA Sequencing Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. DNA-based Targeted Sequencing Picture
    Figure 9. RNA-based Targeted Sequencing Picture
    Figure 10. Global Targeted DNA & RNA Sequencing Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 11. Global Targeted DNA & RNA Sequencing Sales Value Market Share by Type, 2023 & 2030
    Figure 12. Product Picture of Human Biomedical Research
    Figure 13. Product Picture of Plant & Animal Sciences
    Figure 14. Product Picture of Drug Discovery
    Figure 15. Product Picture of Others
    Figure 16. Global Targeted DNA & RNA Sequencing Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 17. Global Targeted DNA & RNA Sequencing Sales Value Market Share by Application, 2023 & 2030
    Figure 18. North America Targeted DNA & RNA Sequencing Sales Value (2019-2030) & (US$ Million)
    Figure 19. North America Targeted DNA & RNA Sequencing Sales Value by Country (%), 2023 VS 2030
    Figure 20. Europe Targeted DNA & RNA Sequencing Sales Value (2019-2030) & (US$ Million)
    Figure 21. Europe Targeted DNA & RNA Sequencing Sales Value by Country (%), 2023 VS 2030
    Figure 22. Asia Pacific Targeted DNA & RNA Sequencing Sales Value (2019-2030) & (US$ Million)
    Figure 23. Asia Pacific Targeted DNA & RNA Sequencing Sales Value by Country (%), 2023 VS 2030
    Figure 24. South America Targeted DNA & RNA Sequencing Sales Value (2019-2030) & (US$ Million)
    Figure 25. South America Targeted DNA & RNA Sequencing Sales Value by Country (%), 2023 VS 2030
    Figure 26. Middle East & Africa Targeted DNA & RNA Sequencing Sales Value (2019-2030) & (US$ Million)
    Figure 27. Middle East & Africa Targeted DNA & RNA Sequencing Sales Value by Country (%), 2023 VS 2030
    Figure 28. Key Countries/Regions Targeted DNA & RNA Sequencing Sales Value (%), (2019-2030)
    Figure 29. United States Targeted DNA & RNA Sequencing Sales Value, (2019-2030) & (US$ Million)
    Figure 30. United States Targeted DNA & RNA Sequencing Sales Value by Type (%), 2023 VS 2030
    Figure 31. United States Targeted DNA & RNA Sequencing Sales Value by Application (%), 2023 VS 2030
    Figure 32. Europe Targeted DNA & RNA Sequencing Sales Value, (2019-2030) & (US$ Million)
    Figure 33. Europe Targeted DNA & RNA Sequencing Sales Value by Type (%), 2023 VS 2030
    Figure 34. Europe Targeted DNA & RNA Sequencing Sales Value by Application (%), 2023 VS 2030
    Figure 35. China Targeted DNA & RNA Sequencing Sales Value, (2019-2030) & (US$ Million)
    Figure 36. China Targeted DNA & RNA Sequencing Sales Value by Type (%), 2023 VS 2030
    Figure 37. China Targeted DNA & RNA Sequencing Sales Value by Application (%), 2023 VS 2030
    Figure 38. Japan Targeted DNA & RNA Sequencing Sales Value, (2019-2030) & (US$ Million)
    Figure 39. Japan Targeted DNA & RNA Sequencing Sales Value by Type (%), 2023 VS 2030
    Figure 40. Japan Targeted DNA & RNA Sequencing Sales Value by Application (%), 2023 VS 2030
    Figure 41. South Korea Targeted DNA & RNA Sequencing Sales Value, (2019-2030) & (US$ Million)
    Figure 42. South Korea Targeted DNA & RNA Sequencing Sales Value by Type (%), 2023 VS 2030
    Figure 43. South Korea Targeted DNA & RNA Sequencing Sales Value by Application (%), 2023 VS 2030
    Figure 44. Southeast Asia Targeted DNA & RNA Sequencing Sales Value, (2019-2030) & (US$ Million)
    Figure 45. Southeast Asia Targeted DNA & RNA Sequencing Sales Value by Type (%), 2023 VS 2030
    Figure 46. Southeast Asia Targeted DNA & RNA Sequencing Sales Value by Application (%), 2023 VS 2030
    Figure 47. India Targeted DNA & RNA Sequencing Sales Value, (2019-2030) & (US$ Million)
    Figure 48. India Targeted DNA & RNA Sequencing Sales Value by Type (%), 2023 VS 2030
    Figure 49. India Targeted DNA & RNA Sequencing Sales Value by Application (%), 2023 VS 2030
    Figure 50. Targeted DNA & RNA Sequencing Industrial Chain
    Figure 51. Targeted DNA & RNA Sequencing Manufacturing Cost Structure
    Figure 52. Channels of Distribution (Direct Sales, and Distribution)
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation

Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest. It offers both quantitative and qualitative information.

The global market for Targeted DNA & RNA Sequencing was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

North American market for Targeted DNA & RNA Sequencing was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Targeted DNA & RNA Sequencing was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Targeted DNA & RNA Sequencing was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of Targeted DNA & RNA Sequencing include Illumina, Inc., F. Hoffmann-La Roche Ltd, Agilent Technologies, GATC Biotech Ag, Oxford Nanopore Technologies, Thermo Fisher Scientific, Inc., DNASTAR Inc., QIAGEN and BGI, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Targeted DNA & RNA Sequencing, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Targeted DNA & RNA Sequencing by region & country, by Type, and by Application.

The Targeted DNA & RNA Sequencing market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Targeted DNA & RNA Sequencing.

Market Segmentation

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Targeted DNA & RNA Sequencing manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Targeted DNA & RNA Sequencing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Targeted DNA & RNA Sequencing in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.